Arthur F. Golden, Director at Turn Therapeutics Inc. (TTRX), bought 9,868 shares at $3.44 ($34K) on 2025-11-24, disclosed to the SEC on 2025-11-25.
Open-market purchase of $34k TTRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| EMR | BUY | 2023-11-13 | $257K | — | Filing → |
| EMR | BUY | 2020-03-11 | $257K | — | Filing → |
| EMR | BUY | 2015-08-10 | $198K | — | Filing → |